PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Hsu, Joanne I., Dayaram, Tajhal, Tovy, Ayala, De Braekeleer, Etienne, Jeong, Mira, Wang, Feng, Zhang, Jianhua, Heffernan, Timothy P. +12 more·2018·Cell stem cell
DOI 10.1016/j.stem.2018.10.004

Cited by (426)

Items 401–426 of 426

  1. From pathogenesis to management: therapy-related myeloid neoplasms in survivors of female-specific cancers
    Yuting Jiang, Jing Tang, Zixuan Li, Mei Hong, Jiaxin Hong · 2026 · Medicine Plus
  2. Reframing—renaming(?)—myelodysplastic syndromes/neoplasms and clonal hematopoiesis of indeterminate potential
    Nicholas C.J. Lee, Rui Miao, Neal S. Young · 2026 · Leukemia
  3. Oncogenic Ppm1d mutations deregulate the p53 pathway in primary mouse gliomas
    Vennesa Valentine, Adam Groth, Joshua Tolliver, Avneesh Saravanapavan, Spencer M. Maingi, Loren B. Weidenhammer, Nerissa T. Williams, Lixia Luo, Matthew S. Waitkus, Sheeba Jacob et al. · 2026 · Neuro-Oncology Pediatrics
  4. Clonal dynamics of CH in CLL
    Sarah Hanache, Koichi Takahashi · 2026 · Blood
  5. Clonal hematopoiesis in the pathogenesis of non-hematologic diseases with therapeutic potential
    Lu Lei, Jie Xiong · 2026 · Cancer Cell International
  6. Calcium signature in the pancreatic cancer : role in the activation of the pancreatic stellate cells and in the progression of the pancreatic cancer
    Silviya Radoslavova · 2021 · theses.fr (ABES)
  7. Origin and pronostic impact of intra-leukemic heterogeneity in acute myeloid leukemias
    Matthieu Duchmann · 2022 · theses.fr (ABES)
  8. Rôle des Hématopoïèses clonales de potentiel indéterminé (CHIP) dans la physiopathologie des maladies cardiovasculaires
    Mélody Dufossée · 2024
  9. Second primary cancers following hematologic malignancies: Epidemiology, pathobiology and clinical management
    Yueyue Pan, Hailing Yang, Junliang Shao, Xinchen Qiang, Qiong Wang · 2026 · Human Vaccines & Immunotherapeutics
  10. Counting the CHIPs: The High-Stakes Role of Clonal Hematopoiesis in Multiple Myeloma
    Morgan Szalay, Ian Seguel Strange, Kyle Banwell, Sophia Campana, Adina Dass, Sereen Hej-Ali, Halima Mohamed, Sahar Khan · 2026 · Biomedicines
  11. Hematopoietic somatic mutations in atherosclerotic cardiovascular disease
    Beatriz L. Ramos-Neble, José J. Fuster · 2026 · Atherosclerosis
  12. No Effect of Ppm1d -Mutant Clonal Hematopoiesis on Atherosclerosis Development in Mice
    Marta Amorós-Pérez, María A. Zuriaga, Virginia Zorita, Beatriz L. Ramos-Neble, Nuria Matesanz, Clara Plötner, Milena Di Carli, Eline L.C. Mol, Rosa Moro, Diego Cuevas et al. · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
  13. How we Investigate Bone Marrow Failure Syndromes in Pediatric Patients
    Marília Bazzo Catto, David J. Young, Luiz Fernando Bazzo Catto · 2026 · Pediatric Hematology and Oncology
  14. Distinct Proteasomal Pathways Drive Oncogenic PPM1D Activation
    Ni Yan, Deumaya Shrestha, Cameron Schluter, Cyrus Jin, Edward Wang, Carmen Da Silva, Ilaria Gritti, Nikolaos Tsopoulidis, Ruxin Yang, Adam Samuel Sperling et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Influence of PPM1D Mutations on Response and Survival Outcomes Following Bispecific Antibody Therapy in Relapsed and Refractory Multiple Myeloma Patients
    Elena Fiori, Martina Bertschinger, Ulrike Bacher, Michele Hoffmann, Henning Nilius, Katja Seipel, Thomas Pabst · 2026 · Biomedicines
  16. Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications
    Wei Du, Shunsuke Koga, Guang Yang, Saar I. Gill, Adam Bagg · 2026 · International Journal of Laboratory Hematology
  17. Hematologic Consequences of Radiopharmaceutical Therapy: From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms
    Wallace Klein Schwengber, Jeremiah Sanders, Aubrey Pinteric, Lindsey Armitage, Daniel S. Childs, MD Thorvardur R. Halfdanarson, Mrinal M. Patnaik, Felipe Martinez, Mohamad Bassam Sonbol, Yael N. Kusne · 2026 · Journal of Nuclear Medicine
  18. Clinical management of clonal hematopoiesis
    Kelly Sharon Chien, Guillermo Garcia‐Manero · 2026 · Cancer
  19. Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients With Heart Failure With Preserved Ejection Fraction
    Minkwan Kim, Vinayak Subramanian, Hamed Tavolinejad, Mateo Sarmiento Bustamante, Bianca Pourmussa, Douglas L. Mann, Ali Javaheri, Mark Richards, Robert Neil Doughty, Ernst R. Rietzschel et al. · 2026 · Circulation Heart Failure
  20. Cardio-Oncological Sequelae of Autologous Stem Cell Transplantation
    Zsófia Sándor, Zoltán V. Varga, Tamás G. Gergely, Laura Horváth, Tamás Masszi, Zsófia D. Drobni, José J. Fuster, Zoltán Pozsonyi · 2026 · JACC Advances
  21. Silent, but not innocent: the emerging role of clonal hematopoiesis in predicting therapy-related myeloid neoplasms
    Şerife Emre Ünsal · 2026 · Frontiers in Oncology
  22. BANF1 at the crossroads of genome stability and innate immunity: emerging implications for hematologic malignancies
    Xia Jiang, Yihan Zhang, Dong Chen, Fenglin Li, Haihui Zhuang, Shuangyue Li, 裴仁治, Ying Lu · 2026 · Frontiers in Immunology
  23. Clonal Hematopoiesis of Indeterminate Potential and Heart Failure: Mechanisms, Risk Stratification, and Therapeutic Implications
    Jun‐Bean Park · 2026 · International Journal of Heart Failure
  24. Clonal Hematopoiesis Across the Cancer Treatment Continuum: A Scoping Review of Clonal Selection, Evolution, and Clinical Outcomes
    Abdullah M. AlShahrani · 2026 · Cancers
  25. Acute myeloid leukemia following icotinib therapy for non-small cell lung cancer: a case report and literature review
    Huiling Huang, Song Lu, Fangqin Tong, Lei Li · 2026 · Frontiers in Oncology
  26. Emergency hematopoiesis in sepsis: A pathway to myeloid clonal expansion
    Olisaemeka Ogbue, Tariq Zuheir Kewan, Serhan Ünlü, Kartik Lakhotiya, Omar Mehkri, Rayna S. Ellison, Francois Fadell, Felipe de Almeida Sartori, Asfand Yar Cheema, Mark D. Orland et al. · 2026 · HemaSphere